Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel

Summary

A study for patients with confirmed locally advanced or metastatic Transitional Cell Carcinoma of the bladder or upper urinary tracts who have developed progressive disease within 12 months of their platinum based chemotherapy. The study aims to compare the overall response rate of cabazitaxel treatment versus best supportive care including single agent chemotherapy.

Timeline

Start

2013-01

Primary completion

2017-11

Completion

2017-11

Drugs

Indications